Thomas Rutherford
- Reproductive Medicine top 0.2%
- Ovarian cancer diagnosis and treatment 67
- Endometriosis Research and Treatment 13
- Obstetrics and Gynecology top 0.2%
- Endometrial and Cervical Cancer Treatments 43
- Uterine Myomas and Treatments 23
- Cancer Research top 1%
- Oncology top 1%
- Cancer Cells and Metastasis 16
- HER2/EGFR in Cancer Research 13
- Immunology top 2%
-
- Intraperitoneal and Appendiceal Malignancies 16
-
- Monoclonal and Polyclonal Antibodies Research 15
- Co-authors
- Gil MorPeter E. SchwartzAyesha B. AlveroDan‐Arin SilasiMasoud AzodiIrene VisintinAlessandro D. SantinMichael Kelly
- Journals
- Gynecologic Oncology (42 papers)International Journal of Gynecological Cancer (13 papers)American Journal of Obstetrics and Gynecology (9 papers)
- Partner nations
- United StatesItalyChina
In The Last Decade
Thomas Rutherford
192 papers receiving 7.8k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Reproductive Medicine 2.3k
- Obstetrics and Gynecology 1.8k
- Cancer Research 1.4k
- Oncology 2.4k
- Immunology 1.2k
Countries citing papers authored by Thomas Rutherford
This map shows the geographic impact of Thomas Rutherford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Rutherford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Rutherford more than expected).
Fields of papers citing papers by Thomas Rutherford
This network shows the impact of papers produced by Thomas Rutherford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Rutherford. The network helps show where Thomas Rutherford may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Rutherford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 8 | |
| 3 | 2023 | 4 | |
| 4 | 2021 | 4 | |
| 5 | Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early-Stage Endometrial Cancerbreakdown → | 2019 | 209 |
| 6 | 2017 | 1 | |
| 7 | 2015 | 26 | |
| 8 | 2015 | 188 | |
| 9 | 2014 | 1 | |
| 10 | 2014 | 27 | |
| 11 | 2012 | 33 | |
| 12 | 2012 | 46 | |
| 13 | 2010 | 40 | |
| 14 | 2010 | 29 | |
| 15 | 2008 | 307 | |
| 16 | 2006 | 39 | |
| 17 | 2005 | 357 | |
| 18 | Phenoxodiol phase Ib/II study in patients with recurrent ovarian cancer that are resistant to ≥ second line chemotherapy | 2004 | 15 |
| 19 | The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines. | 2001 | 50 |
| 20 | 1998 | 64 |
About Thomas Rutherford
Thomas Rutherford is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 195 papers that have together received 7.9k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (67 papers), Endometrial and Cervical Cancer Treatments (43 papers), Uterine Myomas and Treatments (23 papers), Cancer Cells and Metastasis (16 papers), Intraperitoneal and Appendiceal Malignancies (16 papers), Monoclonal and Polyclonal Antibodies Research (15 papers), HER2/EGFR in Cancer Research (13 papers) and Endometriosis Research and Treatment (13 papers). The work is most often cited by research in Reproductive Medicine (2.3k citations), Obstetrics and Gynecology (1.8k citations) and Cancer Research (1.4k citations). Thomas Rutherford has collaborated with scholars based in United States, Italy and China. Frequent co-authors include Gil Mor, Peter E. Schwartz, Ayesha B. Alvero, Dan‐Arin Silasi, Masoud Azodi, Irene Visintin, Alessandro D. Santin, Peter E. Schwartz, Michael Kelly and Stefania Bellone. Their work appears in journals such as Gynecologic Oncology, International Journal of Gynecological Cancer, American Journal of Obstetrics and Gynecology, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.